Drugs / CHS-006
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05757492 Comparator | Apr 2023 → Jul 2024 | hepatocellular carcinoma, non-small cell lung carcinoma | Coherus Oncology, Inc. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CHS-006 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05757492 ↗ |
| Route | Intravenous | “administered via IV Q3W” NCT05757492 ↗ |